Clinical Trial

Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)

Recruiting
View on ClinicalTrials.gov →
Summary
This study is being done to test the feasibility and accuracy of using an ultrasound-guided core needle biopsy technique as a potential tool for staging urothelial carcinoma of the bladder (UCB).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-17; most recent amendment 2026-06-08.
Trial Details
NCT Number NCT07029256
Lead Sponsor Mayo Clinic
Conditions Bladder Urothelial Carcinoma
Enrollment 100 participants
Start Date 2024-07-26
Primary Completion 2030-07-30 (estimated)
Study Completion 2030-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-10